Bicycle Therapeutics plc (BCYC)
$3.80-2.31%Close
BUYRECOVERY · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $264M
- Beta
- 1.68
- P/E (TTM)
- -1.39
- Short % float
- 5.37%
- Days to cover
- 8.7
- SI change
- -0.9%
- 1W
- -5.24%
- 1M
- -1.55%
- vs SPY 1W
- -5.66%
- vs SPY 1M
- -3.62%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on BCYC?
- LOPJLB’s latest quantitative signal on Bicycle Therapeutics plc (BCYC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is BCYC in?
- Bicycle Therapeutics plc (BCYC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Bicycle Therapeutics plc (BCYC) do?
- Bicycle Therapeutics plc, founded in 2009 and based in Cambridge, UK, is a clinical-stage biopharmaceutical company. Its core mission is to create innovative therapeutic classes for diseases currently lacking effective treatments. The company's leading investigational product, BT1718, is a Bicycle Toxin Conjugate (BTC) that is undergoing Phase I/IIa clinical trials. This candidate is engineered…